IVIg for TS‐HDS and FGFR‐3 antibody–positive small‐fiber neuropathy: A fading signal for efficacy?

See article on pages 363–370 in this issue.

Saved in:
Bibliographic Details
Published in:Muscle & nerve Vol. 67; no. 5; pp. 339 - 340
Main Authors: Katzberg, Hans D., Barnett, Carolina
Format: Journal Article
Language:English
Published: Hoboken, USA John Wiley & Sons, Inc 01-05-2023
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract See article on pages 363–370 in this issue.
AbstractList See article on pages 363–370 in this issue .
See article on pages 363–370 in this issue.
Author Katzberg, Hans D.
Barnett, Carolina
Author_xml – sequence: 1
  givenname: Hans D.
  orcidid: 0000-0002-4716-3304
  surname: Katzberg
  fullname: Katzberg, Hans D.
  email: hans.katzberg@utoronto.ca
  organization: Division of Neurology, Toronto General Hospital/University Health Network
– sequence: 2
  givenname: Carolina
  orcidid: 0000-0001-5546-0221
  surname: Barnett
  fullname: Barnett, Carolina
  organization: Division of Neurology, Toronto General Hospital/University Health Network
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36762497$$D View this record in MEDLINE/PubMed
BookMark eNp1kNFqFDEUhoNU7LZ64QtIwBu9mPZkMpNkvCmluu1CRXBX8W7IZE7WLDOTNdlR5q6PIPiGfRLTbvVCEALhTz4-zvmPyMHgByTkOYMTBpCf9mM8yaUCeERmDCqZFWWlDsgMWKEywasvh-Qoxg0AMCXkE3LIhRR5UckZ2Sw-L9bU-kBXy9ubn1dvl1QPLZ1fzj-myFPYuca30-3Nr62Pbue-I4297rr0a12DgQ44Br_Vu6_TG3pOrW7dsKbRrQfd3XvRWme0mc6eksdWdxGfPdzHZDV_t7q4yq4_XC4uzq8zw5WCzCIDLspciLIFg0bLlovGCouomkaDKrBAkY5lvOKFgVwyXqbtC2EwvR2TV3vtNvhvI8Zd3btosOv0gH6MdS5lKZiCqkzoy3_QjR9DGjxR6q4rrqoqUa_3lAk-xoC23gbX6zDVDOq7_uv-Xpv6T-yLB-PY9Nj-Jf8UnoDTPfDDdTj931S__7TcK38DSBGTOA
CitedBy_id crossref_primary_10_1097_CND_0000000000000478
crossref_primary_10_1212_NXI_0000000000200248
Cites_doi 10.3390/pathophysiology28040035
10.1177/1756285617744484
10.1212/WNL.0000000000012711
10.1093/brain/awz333
10.1212/WNL.0000000000011919
10.1002/ana.26268
10.1007/s00415-020-10033-z
10.1002/mus.27745
10.1136/jnnp-2019-321849
10.1097/WCO.0000000000001103
10.1212/WNL.0000000000010988
10.1002/mus.27245
10.2337/dc06-0224
10.1002/mus.26748
10.1002/mus.23256
ContentType Journal Article
Copyright 2023 Wiley Periodicals LLC.
Copyright_xml – notice: 2023 Wiley Periodicals LLC.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7TK
7TM
7TS
7U7
7U9
C1K
H94
K9.
NAPCQ
7X8
DOI 10.1002/mus.27800
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Physical Education Index
Toxicology Abstracts
Virology and AIDS Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Nursing & Allied Health Premium
Virology and AIDS Abstracts
Toxicology Abstracts
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Neurosciences Abstracts
Physical Education Index
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef

Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-4598
EndPage 340
ExternalDocumentID 10_1002_mus_27800
36762497
MUS27800
Genre editorial
Comment
Editorial
Commentary
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
123
1CY
1L6
1OB
1OC
1ZS
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AAQQT
AASGY
AAWTL
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR1
DR2
DRFUL
DRMAN
DRSTM
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
FYBCS
G-S
G.N
GNP
GODZA
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M6M
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWD
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TUS
TWZ
UB1
V2E
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
XPP
XV2
YCJ
ZGI
ZXP
ZZTAW
~IA
~WT
CGR
CUY
CVF
ECM
EIF
NPM
AAMNL
AAYXX
CITATION
7T5
7TK
7TM
7TS
7U7
7U9
C1K
H94
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c3880-fe103652665d0ceca7d36bf6fee8bba084e4e64e6f13934c02713578046cef13
IEDL.DBID 33P
ISSN 0148-639X
IngestDate Sat Aug 17 02:09:05 EDT 2024
Thu Oct 10 22:02:27 EDT 2024
Fri Nov 22 01:07:56 EST 2024
Sat Sep 28 08:14:48 EDT 2024
Sat Aug 24 01:00:31 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3880-fe103652665d0ceca7d36bf6fee8bba084e4e64e6f13934c02713578046cef13
Notes SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ORCID 0000-0001-5546-0221
0000-0002-4716-3304
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mus.27800
PMID 36762497
PQID 2801863899
PQPubID 1016420
PageCount 2
ParticipantIDs proquest_miscellaneous_2775618095
proquest_journals_2801863899
crossref_primary_10_1002_mus_27800
pubmed_primary_36762497
wiley_primary_10_1002_mus_27800_MUS27800
PublicationCentury 2000
PublicationDate May 2023
2023-05-00
20230501
PublicationDateYYYYMMDD 2023-05-01
PublicationDate_xml – month: 05
  year: 2023
  text: May 2023
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Rochester
PublicationTitle Muscle & nerve
PublicationTitleAlternate Muscle Nerve
PublicationYear 2023
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2021; 64
2021; 97
2023; 67
2020; 95
2020; 61
2021; 28
2020; 91
2022; 91
2022; 35
2006; 29
2020; 267
2018; 11
2021; 96
2012; 45
2019; 142
36367813 - Muscle Nerve. 2023 May;67(5):363-370
e_1_2_6_10_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_13_1
e_1_2_6_14_1
e_1_2_6_3_1
e_1_2_6_11_1
e_1_2_6_2_1
e_1_2_6_12_1
e_1_2_6_15_1
e_1_2_6_16_1
References_xml – volume: 97
  start-page: 791
  year: 2021
  end-page: 792
  article-title: Reader response: intravenous immunoglobulin therapy in patients with painful idiopathic small fiber neuropathy
  publication-title: Neurology.
– volume: 96
  start-page: e2534
  year: 2021
  end-page: e2545
  article-title: Intravenous immunoglobulin therapy in patients with painful idiopathic small fiber neuropathy
  publication-title: Neurology.
– volume: 91
  start-page: 49
  year: 2020
  end-page: 57
  article-title: Clinical characterisation of sensory neuropathy with anti‐FGFR3 autoantibodies
  publication-title: J Neurol Neurosurg Psychiatry.
– volume: 64
  start-page: 70
  year: 2021
  end-page: 76
  article-title: TS‐HDS and FGFR3 antibodies in small fiber neuropathy and dysautonomia
  publication-title: Muscle Nerve.
– volume: 61
  start-page: 512
  year: 2020
  end-page: 515
  article-title: Cryptogenic small‐fiber neuropathies: serum autoantibody binding to trisulfated heparan disaccharide and fibroblast growth factor receptor‐3
  publication-title: Muscle Nerve.
– volume: 45
  start-page: 866
  year: 2012
  end-page: 872
  article-title: Clinical and laboratory features of neuropathies with serum IgM binding to TS‐HDS
  publication-title: Muscle Nerve.
– volume: 142
  start-page: 3728
  year: 2019
  end-page: 3736
  article-title: Diagnostic criteria for small fibre neuropathy in clinical practice and research
  publication-title: Brain.
– volume: 267
  start-page: 3499
  year: 2020
  end-page: 3507
  article-title: Long‐term efficacy of immunoglobulins in small fiber neuropathy related to Sjogren's syndrome
  publication-title: J Neurol.
– volume: 28
  start-page: 544
  year: 2021
  end-page: 550
  article-title: Small fiber neuropathy in sarcoidosis
  publication-title: Pathophysiology.
– volume: 67
  start-page: 363
  year: 2023
  end-page: 370
  article-title: A double‐blind placebo‐controlled pilot study of immunoglobulin for small fiber neuropathy associated with TS‐HDS and FGFR‐3 autoantibodies
  publication-title: Muscle Nerve.
– volume: 91
  start-page: 66
  year: 2022
  end-page: 77
  article-title: Novel autoantibodies in idiopathic small fiber neuropathy
  publication-title: Ann Neurol.
– volume: 29
  start-page: 1294
  year: 2006
  end-page: 1299
  article-title: Lifestyle intervention for pre‐diabetic neuropathy
  publication-title: Diabetes Care.
– volume: 35
  start-page: 545
  year: 2022
  end-page: 552
  article-title: Small fiber neuropathies: expanding their etiologies
  publication-title: Curr Opin Neurol.
– volume: 95
  start-page: 1005
  year: 2020
  end-page: 1014
  article-title: Idiopathic distal sensory polyneuropathy: ACTTION diagnostic criteria
  publication-title: Neurology.
– volume: 11
  start-page: 1756285617744484
  year: 2018
  article-title: IVIg for apparently autoimmune small fiber polyneuropathy: first analysis of efficacy and safety
  publication-title: Ther Adv Neurol Disord.
– ident: e_1_2_6_6_1
  doi: 10.3390/pathophysiology28040035
– ident: e_1_2_6_7_1
  doi: 10.1177/1756285617744484
– ident: e_1_2_6_15_1
  doi: 10.1212/WNL.0000000000012711
– ident: e_1_2_6_3_1
  doi: 10.1093/brain/awz333
– ident: e_1_2_6_8_1
  doi: 10.1212/WNL.0000000000011919
– ident: e_1_2_6_14_1
  doi: 10.1002/ana.26268
– ident: e_1_2_6_5_1
  doi: 10.1007/s00415-020-10033-z
– ident: e_1_2_6_13_1
  doi: 10.1002/mus.27745
– ident: e_1_2_6_10_1
  doi: 10.1136/jnnp-2019-321849
– ident: e_1_2_6_4_1
  doi: 10.1097/WCO.0000000000001103
– ident: e_1_2_6_2_1
  doi: 10.1212/WNL.0000000000010988
– ident: e_1_2_6_11_1
  doi: 10.1002/mus.27245
– ident: e_1_2_6_16_1
  doi: 10.2337/dc06-0224
– ident: e_1_2_6_12_1
  doi: 10.1002/mus.26748
– ident: e_1_2_6_9_1
  doi: 10.1002/mus.23256
SSID ssj0001867
Score 2.452399
Snippet See article on pages 363–370 in this issue.
See article on pages 363–370 in this issue .
SourceID proquest
crossref
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 339
SubjectTerms Antibodies
Disaccharides - immunology
Fibroblast growth factor receptors
Heparin - immunology
Humans
Immunoglobulin M
Immunoglobulins
Immunoglobulins, Intravenous - therapeutic use
Intravenous administration
Neuropathy
Receptor, Fibroblast Growth Factor, Type 3 - immunology
Small Fiber Neuropathy - immunology
Small Fiber Neuropathy - therapy
Title IVIg for TS‐HDS and FGFR‐3 antibody–positive small‐fiber neuropathy: A fading signal for efficacy?
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmus.27800
https://www.ncbi.nlm.nih.gov/pubmed/36762497
https://www.proquest.com/docview/2801863899
https://search.proquest.com/docview/2775618095
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT-MwEB4BB8SF9yO8ZBAHLlmaR5OwHFYIKOUAQrQgbpEfYwSCFFGK1Bs_YSX-Ib9kZ5w2CK2QkJByiOPYjjwezzfx-DPAVoZxmO7q2LcYSj82KvBlLDnABpXCIEmto2tqttKz6-zwiGly9oZ7YUp-iOqHG2uGm69ZwaXq7nyQhj70ur_ClPAOzb_kJbjtG9F5NQszUVsZvpj5ZIWvh6xCtXCnKvnZFv0HMD_jVWdwGlM_-tRpmBzgTLFfDowZGMFiFsZPByvpc3B3cnVyIwixinbr_fVv87AlZGFE47hxQcmIEs-3qmP6769vZVzXC4rug7y_p1zLUSbCMWHygcb932JfWBeLLzgchJrlepHJKaTu_5mHduOofdD0B-cu-JqpYUhsAdm1Opnuuqlp1DI1UaJsYhEzpWQtizHGhC5L8DGKNXm2AZPmkKutkZ4twFjRKXAJhFF1SZBHB6kysalFEkkskaVxYRO9G9Q92BwKIH8s2TXykkc5zKnTctdpHqwORZMPFIxyMpYwkwN6sFFlk2rweocssONKp4QOMwKRHiyWIq1aYaI68jxTD7ad5L5uPj-9bLmb5e-_ugITfCx9GRi5CmPPTz1cg9Gu6a27UfoPuyDrvg
link.rule.ids 315,782,786,1408,27933,27934,46064,46488
linkProvider Wiley-Blackwell
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fS9xAEB-qgu2LWvsvrW1X6UNfUi_JXhKlUKR63qEn4l3Ft7B_ZkuL5qTnFe7NjyD4Df0kndncpYgIgpCHbDabDTszO7_dnf0twKccZZxtGBk6jFUorY5CJRUH2KDWGKWZ83RN7V52cJJv7zBNztfpXpiKH6KecGPL8P01GzhPSK__Zw09Gw2_xBkBnhmYkykpIm_gSA7rfpip2qoAxjwkP3wy5RVqxOt10dve6A7EvI1YvctpLT7uZ5dgYQI1xValG8_hCZbLMN-dLKa_gN-d485PQaBV9Hs3l1ft7Z5QpRWt3dYRJRNKXPzSAzu-ubyuQrv-ohieqdNTynUcaCI8GSafaTzeFFvC-XB8wREhVC1_F5mfQpnxt5fQb-30v7fDydELoWF2GJJcRK6tSd67aRsGjcpskmqXOsRca9XIJUpM6XKEIBNpaHAbMW8OjbYN0rNXMFsOSnwDwuqmItRjokxbaRuJQpJL4kg1XGo2omYAa1MJFOcVwUZRUSnHBTVa4RstgJWpbIqJjVFOziJmfsAAVutssg5e8lAlDnzpjABiTjgygNeVTOtamKuOBp9ZAJ-96O6vvuj-6Pmbtw9_9SM8bfe7-8V-52DvHTzjU-qrOMkVmL34M8L3MDO0ow9eZf8BmYHv5g
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NT9wwEB0VKqFeKPQDUih1qx56Sdkk3iTAoUJd0l21INRdELfIH2MEgixi2Up74ydU4h_ySzrj7KZCVaVKlXKI4ziO_Dye53jyDPA-RxlnW0aGDmMVSqujUEnFATaoNUZp5rxcU7efHZzknT2WydmZ_QtT60M0H9zYMvx4zQZ-Zd3mb9HQy_HoY5wR35mDx5JoOAvnJ8lhMwyzUlsdv5iH5IZPZrJCrXizKfrQGf3BMB8SVu9xiqf_9a5LsDglmmK37hnL8AirZ7CwP11Kfw7nvePeqSDKKgb9-9uf3U5fqMqK4kvxnZIJJW7O9NBO7m_v6sCuHyhGl-rignIdh5kIL4XJOxpPtsWucD4YX3A8CFXLz0VWp1Bm8ukFDIq9weduON14ITSsDUO4ReTY2uS727Zl0KjMJql2qUPMtVatXKLElA5H_DGRhqa2Eavm0FzbIF17CfPVsMJVEFa3FXEeE2XaSttKFBIsiaOO4VKzFbUDeDcDoLyq5TXKWkg5LqnRSt9oAazPoCmnFkY5OSPM6oABvG2yyTZ4wUNVOPSlM6KHObHIAFZqSJtaWKmOpp5ZAB88cn-vvtw_6vuTV_9-6xtYOOwU5bfewdc1eMJb1NdBkuswf3M9xtcwN7LjDd9hfwHE0e6M
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IVIg+for+TS%E2%80%90HDS+and+FGFR%E2%80%903+antibody%E2%80%93positive+small%E2%80%90fiber+neuropathy%3A+A+fading+signal+for+efficacy%3F&rft.jtitle=Muscle+%26+nerve&rft.au=Katzberg%2C+Hans+D.&rft.au=Barnett%2C+Carolina&rft.date=2023-05-01&rft.pub=John+Wiley+%26+Sons%2C+Inc&rft.issn=0148-639X&rft.eissn=1097-4598&rft.volume=67&rft.issue=5&rft.spage=339&rft.epage=340&rft_id=info:doi/10.1002%2Fmus.27800&rft.externalDBID=10.1002%252Fmus.27800&rft.externalDocID=MUS27800
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0148-639X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0148-639X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0148-639X&client=summon